Docosahexaenoic acid in ARSACS: observations in two patients

Spastic ataxia of Charlevoix-Saguenay is a neurodegenerative condition due to mutations in the SACS gene and without a cure. Attempts to treatments are scarce and limited to symptomatic drugs.

Source: BMC Neurology - May 28, 2020 Category: Neurology Authors: Ivana Ricca, Alessandra Tessa, Rosanna Trovato, Giacomo Maria Bacci and Filippo Maria Santorelli Tags: Case report Source Type: research